Neuronetics (STIM) Tops Q4 EPS by 7c ; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q4 EPS of ($0.19), $0.07 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $19.85 million.

GUIDANCE:

Neuronetics sees Q1 2024 revenue of $16.7-17.7 million, versus the consensus of $16.98 million.

Neuronetics sees FY2024 revenue of $78-80 million, versus the consensus of $78.64 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• BMO Capital Reiterates Outperform Rating on HF Sinclair (DINO)
• Cosmos Health posts 31% revenue gain in Q2 and H1 2026